Table 4.
Prospective association of baseline metabolic syndrome components (t) with psychopathology at the next assessment (t + 1)
| 0→2 Years | 2→6 Years | ||||||
|---|---|---|---|---|---|---|---|
| Predictor (t) | Outcome (t + 1) | B | SE | P | B | SE | P |
| Number of components | IDS | −0.0168 | 0.0106 | .112 | 0.0230 | 0.0126 | .068 |
| Number of components | BAI | 0.0002 | 0.0152 | .991 | 0.0253 | 0.0191 | .185 |
| Number of components | Antidepressant use (vs. none) | −0.0535 | 0.0555 | .335 | 0.0642 | 0.0707 | .364 |
| Waist | IDS | −0.0226 | 0.0158 | .152 | 0.0237 | 0.0175 | .176 |
| Waist | BAI | 0.0018 | 0.0114 | .874 | 0.0106 | 0.0135 | .432 |
| Waist | Antidepressant use (vs. none) | 0.0023 | 0.0052 | .660 | −0.0003 | 0.0068 | .970 |
| HDL | IDS | 0.1553 | 0.4951 | .754 | −0.5917 | 0.5323 | .266 |
| HDL | BAI | −0.0500 | 0.3582 | .889 | −0.6080 | 0.3903 | .119 |
| HDL | Antidepressant use (vs. none) | 0.1223 | 0.1603 | .445 | −0.5069 | 0.2265 | .025 |
| Triglycerides | IDS | 0.4046 | 0.8218 | .623 | 0.6401 | 0.9383 | .495 |
| Triglycerides | BAI | 0.4294 | 0.6186 | .488 | 0.6835 | 0.6775 | .313 |
| Triglycerides | Antidepressant use (vs. none) | 0.0730 | 0.0652 | .263 | 0.1116 | 0.0872 | .200 |
| SBP | IDS | −0.0132 | 0.0104 | .202 | −0.0096 | 0.0117 | .409 |
| SBP | BAI | −0.0132 | 0.0076 | .085 | −0.0088 | 0.0084 | .294 |
| SBP | Antidepressant use (vs. none) | −0.0006 | 0.0037 | .878 | 0.0042 | 0.0055 | .448 |
| Glucose | IDS | 1.3291 | 2.8651 | .643 | −1.5277 | 3.3214 | .646 |
| Glucose | BAI | 0.7495 | 2.1295 | .725 | 0.2202 | 2.3306 | .925 |
| Glucose | Antidepressant use (vs. none) | −0.1252 | 0.0746 | .093 | 0.0641 | 0.0809 | .428 |
Estimates were obtained from generalized estimating equations. Analyses were adjusted for baseline values of the outcome, age, sex, education, smoking, alcohol use, and physical activity.